Research programme: epigenetic modulators - OryzonAlternative Names: LSD1 inhibitors - Oryzon; ORY 3001
Latest Information Update: 11 Mar 2017
At a glance
- Originator Oryzon
- Class Small molecules
- Mechanism of Action Enzyme modulators; Lysine specific demethylase 1 inhibitors; Monoamine oxidase B inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Autoimmune disorders; Cancer; Inflammation; Viral infections